首页> 外文OA文献 >A Comparison of Prophylactic Versus On-Demand Treatment Regimens of Coagulation Factor VIII for Bleeding and Joint Outcomes in Hemophilia a Patients Without Inhibitors: A Systematic Review and Meta-Analysis

【2h】

A Comparison of Prophylactic Versus On-Demand Treatment Regimens of Coagulation Factor VIII for Bleeding and Joint Outcomes in Hemophilia a Patients Without Inhibitors: A Systematic Review and Meta-Analysis

机译：凝血因子VIII凝血因子VIII对血友病患者出血和关节成果的预防性与需求治疗方案的比较：系统评价和荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
B Oak; S Nambiar; S Springs; T Eguale;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy of emicizumab prophylaxis versus factor VIII prophylaxis for treatment of hemophilia A without inhibitors: network meta-analysis and sub-group analyses of the intra-patient comparison of the HAVEN 3 trial [J] . Reyes Adriana, Revir Cedric, Niggli Markus, Current medical research and opinion . 2019,第12期

机译：Emicizumab预防对因子VIII预防治疗血友病A没有抑制剂的疗效：网络元分析和患者内避风中的患者内部比较的分析
2. CHARACTERISTICS OF PATIENTS WITH AND WITHOUT BLEEDING IN A PIVOTAL TRIAL OF EXTENDED HALF-LIFE, PEGYLATED, FULL-LENGTH RECOMBINANT FACTOR VIII (BAX855) FOR THE PROPHYLACTIC TREATMENT OF HEMOPHILIA A [J] . Ma Alice, Klamroth Robert, Manco-Johnson Marilyn, American Journal of Hematology . 2016,第9期

机译：延长半衰期，聚乙二醇化，全长重组因子VIII（BAX855）的半衰期关键试验中有无出血的患者的特征
3. Rapid Acquisition of Immunologic Tolerance to Factor VIII and Disappearance of Anti-factor VIII IgG4 After Prophylactic Therapy in a Hemophilia A Patient With High-titer Factor VIII Inhibitor [J] . Moorehead Paul C., Thibeault Lisa, Tuttle Angie, Journal of pediatric hematology/oncology: Official journal of the American Society of Pediatric Hematology/Oncology . 2015,第4期

机译：血友病的预防性治疗后快速获得对因子VIII的免疫耐受和抗因子VIII IgG4的消失高血型因子VIII抑制剂的患者
4. Inactiwatlon of Animal Factor VIII by human Factor VIII Inhibitors: Inwestigation of Plasma from Patients with Inhibitors in congenital Hemophilia I and from Patients with acquired Hemophilia A [C] . V. Aumann, G. Lutze (Jr.), G. Lutze (Sen.), Hemophilie-Symposion . 2003

机译：人为因子VIII抑制剂的动物因子VIII的乙酰丁酮：先天性血友病药中抑制剂患者的血浆中的预防
5. Immunity and tolerance to coagulation co-factor VIII in the treatment of hemophilia A. [D] . Skupsky, Jonathan. 2009

机译：血友病A治疗中对凝血因子VIII的免疫力和耐受性。
6. Use of recombinant factor VIIa for the prevention and treatment of bleeding in patients without hemophilia: a systematic review and meta-analysis [O] . Yulia Lin, Simon Stanworth, Janet Birchall, 2011

机译：重组凝血因子VIIa在预防和治疗无血友病患者的出血中的应用：系统评价和荟萃分析
7. Reply: RE: Reyes A, Révil C, Niggli M, et al. Efficacy of emicizumab prophylaxis versus factor VIII prophylaxis for treatment of hemophilia A without inhibitors: network meta-analysis and sub-group analyses of the intra-patient comparison of the HAVEN 3 trial. Curr Med Res Opin. 2019;35(12):2079–2087 [O] . Adriana Reyes, Cédric Révil, Markus Niggli, 2020

机译：回复：Re：Reyes A，Révilc，niggli m等。 eMicizumab预防对因子VIII预防治疗血友病A没有抑制剂的疗效：网络荟萃分析和避风中的患者内部比较的分析。 Curr Med Res opp。 2019; 35（12）：2079-2087
8. Cooperative Study of Spontaneously-Occurring Factor VIII Inhibitors in Patients with Hemophilia A [R] . Shapiro, S. S. 1981

机译：血友病a患者自发性因子VIII抑制剂的合作研究

A Comparison of Prophylactic Versus On-Demand Treatment Regimens of Coagulation Factor VIII for Bleeding and Joint Outcomes in Hemophilia a Patients Without Inhibitors: A Systematic Review and Meta-Analysis

著录项

引文网络

相似文献

相关主题

期刊订阅